Clarient, Inc. (CLRT) CEO Issues Performance Update; Anticipates Profitable Growth in 2009
Clarient, Inc. is focused on providing the services, resources and critical information necessary to improve the quality and reduce the cost of patient care as well as accelerating the drug development process. Today, the company released the following corporate update to shareholders: Dear Clarient Shareholders: After a crucial Allied victory early in World War II, Winston Churchill observed, “Now this is not the end. It is not even the beginning of the end. But it is, perhaps, the end of the beginning.” January marked Clarient’s four year anniversary. During that time, we have made tremendous strides in transforming our business…